Bank of New York Mellon’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Buy |
394,990
+50,932
| +15% | +$139K | ﹤0.01% | 3080 |
|
|
2025
Q1 | $578K | Buy |
344,058
+7,230
| +2% | +$12.1K | ﹤0.01% | 3363 |
|
|
2024
Q4 | $549K | Buy |
336,828
+9,905
| +3% | +$16.1K | ﹤0.01% | 3454 |
|
|
2024
Q3 | $1.36M | Sell |
326,923
-104,821
| -24% | -$436K | ﹤0.01% | 2956 |
|
|
2024
Q2 | $2.36M | Buy |
431,744
+90,423
| +26% | +$494K | ﹤0.01% | 2706 |
|
|
2024
Q1 | $3.41M | Sell |
341,321
-21,691
| -6% | -$217K | ﹤0.01% | 2500 |
|
|
2023
Q4 | $1.48M | Sell |
363,012
-6,865
| -2% | -$28K | ﹤0.01% | 2973 |
|
|
2023
Q3 | $1.43M | Buy |
369,877
+742
| +0.2% | +$2.87K | ﹤0.01% | 2982 |
|
|
2023
Q2 | $2.2M | Buy |
369,135
+9,880
| +3% | +$58.9K | ﹤0.01% | 2779 |
|
|
2023
Q1 | $1.17M | Sell |
359,255
-4,902
| -1% | -$16K | ﹤0.01% | 3068 |
|
|
2022
Q4 | $1.44M | Sell |
364,157
-7,507
| -2% | -$29.7K | ﹤0.01% | 3020 |
|
|
2022
Q3 | $2.23M | Buy |
371,664
+62,182
| +20% | +$373K | ﹤0.01% | 2776 |
|
|
2022
Q2 | $1.99M | Sell |
309,482
-45,960
| -13% | -$296K | ﹤0.01% | 2837 |
|
|
2022
Q1 | $2.94M | Sell |
355,442
-1,369
| -0.4% | -$11.3K | ﹤0.01% | 2713 |
|
|
2021
Q4 | $5.52M | Buy |
356,811
+34,533
| +11% | +$535K | ﹤0.01% | 2412 |
|
|
2021
Q3 | $7.26M | Buy |
322,278
+234,977
| +269% | +$5.29M | ﹤0.01% | 2299 |
|
|
2021
Q2 | $1.72M | Buy |
87,301
+38,196
| +78% | +$751K | ﹤0.01% | 3095 |
|
|
2021
Q1 | $1.64M | Buy |
+49,105
| New | +$1.64M | ﹤0.01% | 3037 |
|